QIAGEN N.V.
QGEN
$55.01
$0.761.40%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 532.58M | 533.54M | 483.46M | 521.20M | 501.87M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 532.58M | 533.54M | 483.46M | 521.20M | 501.87M |
| Cost of Revenue | 187.78M | 185.95M | 159.98M | 171.09M | 179.82M |
| Gross Profit | 344.80M | 347.59M | 323.48M | 350.11M | 322.05M |
| SG&A Expenses | 143.11M | 148.75M | 137.94M | 141.71M | 140.66M |
| Depreciation & Amortization | 15.65M | 15.12M | 15.27M | 15.32M | 16.10M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 395.29M | 397.57M | 356.98M | 376.73M | 381.02M |
| Operating Income | 137.29M | 135.97M | 126.48M | 144.48M | 120.85M |
| Income Before Tax | 134.73M | 126.82M | 119.55M | 125.85M | 116.46M |
| Income Tax Expenses | 4.68M | 30.57M | 28.79M | 37.53M | 18.40M |
| Earnings from Continuing Operations | 130.04M | 96.25M | 90.76M | 88.32M | 98.06M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 130.04M | 96.25M | 90.76M | 88.32M | 98.06M |
| EBIT | 137.29M | 135.97M | 126.48M | 144.48M | 120.85M |
| EBITDA | 188.26M | 185.45M | 170.39M | 177.03M | 170.84M |
| EPS Basic | 0.63 | 0.47 | 0.44 | 0.43 | 0.48 |
| Normalized Basic EPS | 0.43 | 0.43 | 0.40 | 0.46 | 0.38 |
| EPS Diluted | 0.63 | 0.46 | 0.43 | 0.42 | 0.48 |
| Normalized Diluted EPS | 0.43 | 0.42 | 0.40 | 0.46 | 0.38 |
| Average Basic Shares Outstanding | 206.03M | 205.87M | 207.46M | 207.12M | 205.33M |
| Average Diluted Shares Outstanding | 207.53M | 207.27M | 209.18M | 207.12M | 206.92M |
| Dividend Per Share | 0.00 | 0.00 | 0.26 | -- | -- |
| Payout Ratio | 41.71% | -- | -- | -- | -- |